Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quince Therapeutics, Inc. - Common Stock (NQ:QNCX)

3.482 +0.812 (+30.42%)
Streaming Delayed Price Updated: 3:56 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quince Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.41% to 34,088.68 while the NASDAQ rose 1.27% to 11,659.16. The S&P 500... 
Via Benzinga
News headline image
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Jumps 100 Points; Crude Oil Down 1% ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.29% to 34,047.95 while the NASDAQ rose 0.88% to 11,613.37. The S&P... 
Via Benzinga
News headline image
KERN Stock Alert: Akerna Plans to Merge With Gryphon Digital Mining ↗
Akerna (KERN) stock is on the move Friday after the company revealed plans to merge with crypto company Gryphon Digital Mining. 
Via InvestorPlace
News headline image
Why Is Quince Therapeutics (NASDAQ:QNCX) Stock Up 53% Today? ↗
Quince Therapeutics (QNCX) stock is rocketing higher on Friday after completing an asset sale to Lighthouse Pharmaceuticals. 
Via InvestorPlace
News headline image
Quince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals
From Quince Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's trading, 138 companies set new 52-week lows. 
Via Benzinga
News headline image
Quince Therapeutics Presents Preclinical Data at MHSRS 2022 Demonstrating Preclinical Efficacy of Bone-targeting Platform for Traumatic Bone Injury
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 236 companies set new 52-week lows. 
Via Benzinga
News headline image
Quince Therapeutics Presents Preclinical Data at ASBMR 2022 Demonstrating Application of Bone-targeting Platform for Spinal Fusion and Bone Cancer Indications
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Quince Therapeutics Presents Preclinical Data at OI 2022 Demonstrating Potential of a Targeted Anabolic for Accelerated Bone Healing of Osteogenesis Imperfecta Fractures
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Quince Therapeutics to Present at Upcoming Scientific Meetings
From Quince Therapeutics, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 250 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
News headline image
Quince Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022
From Quince Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.